Form 4 for DLB Dolby Laboratories, Inc.
Accepted 2024-11-22 00:00:00 ET · period of report 2024-11-21 · accession 0000950170-24-130316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-22 | 2024-11-21 | DLB | GOTCHER PETER C | Dir | S - Sale | $78.96 | -6,079 | 37.6K | -14% | -$480.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-11-21 | S | D | 6,079 | $78.96 | 37,593 | D | — | — | (F1) The shares were sold in multiple transactions at prices ranging from $78.85 to $78.98, inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. (F2) Shares held following the reported transaction include 2,952 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest. |